Stocks · Healthcare · Medical - Care Facilities
LifeStance Health Group, Inc. LFST
$11.83 -0.67% Close, Oct 2, 2026 · NASDAQ · Market cap $4.59B
Strong growthHigh qualityStrong trendInexpensive vs sectorLow risk
Next earnings report: Nov 5, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Over the past year the stock returned +117.1%, ahead of the S&P 500 by 102.0 percentage points.
- Earnings beat analyst estimates in each of the last 10 quarters (average surprise over the last four: +100.0%).
- The stock is in an uptrend: above its 200-day average for 227 trading days, with the 50-day average above the 200-day.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 32%
- FCF growth (TTM, YoY)Top 20%
- Revenue growth, 3-year CAGRTop 33%
- Revenue growth accelerationTop 20%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 27%
- Gross marginBottom 22%
- Operating marginTop 34%
- Cash conversion (OCF / net income)Top 10%
- Accruals (lower is better)Top 44%
- Net debt / EBITDA (lower is better)Top 30%
- Interest coverTop 19%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 27%
- Free-cash-flow yieldTop 19%
- EBITDA / enterprise valueTop 31%
- Sales / enterprise valueTop 38%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 12%
- 6-month returnTop 11%
- 1-year return vs S&P 500Top 12%
- Distance from 52-week highTop 20%
- Trend checklist (0–4)Top 39%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 4%
- Consecutive EPS beatsTop 6%
- Share of analysts rating BuyTop 41%
- Upside to consensus price targetBottom 25%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 19%
- Maximum drawdown, 3 yearsTop 30%
- Beta vs S&P 500 (lower is better)Top 27%
- Net debt / EBITDA (lower is better)Top 30%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 16.5% | 20.4% | ↑ |
| Gross margin | 32.5% | 33.6% | ↑ |
| Operating margin | -0.0% | 4.9% | ↑ |
| FCF margin | 9.1% | 13.3% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 20.4% | 16.5% | ↑ | Top 32% |
| Gross margin | 33.6% | 32.5% | ↑ | Bottom 22% |
| Operating margin | 4.9% | -0.0% | ↑ | Top 34% |
| Net margin | 3.2% | -1.2% | ↑ | — |
| Free-cash-flow margin | 13.3% | 9.1% | ↑ | — |
| Return on invested capital | 3.0% | — | Top 27% | |
| Revenue growth, 3-year CAGR | 18.3% | — | Top 33% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 3.00×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -7.7%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 4.4%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -34.7 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- -0.19×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 7.8×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 2.13%
- Shareholder yield
- 2.13%
- Share count change, 1 year
- +0.1%
- Share count change, 3-year CAGR
- +2.2%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 6, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 10
- Beats in the last 8 reports
- 8 of 8
- Average EPS surprise, last 4
- +100.0%
- Average 2-day reaction, last 8
- +6.3%
- Positive 20 days after report
- 5 of 8
Analysts
- Consensus price target
- $13.86
- Target vs current price
- +17.2%
- Analysts with a rating
- 11
- Share rating Buy or Strong Buy
- 82%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 6, 2026 | +83.2% | +2.8% | +17.9% | +24.3% | — |
| May 7, 2026 | +300.0% | +20.2% | +10.1% | +3.8% | +43.2% |
| Feb 25, 2026 | +3291.5% | +3.8% | +1.8% | -9.7% | +7.6% |
| Nov 6, 2025 | +127.7% | +29.9% | +33.9% | +34.3% | +47.8% |
| Aug 7, 2025 | +66.7% | -1.0% | +32.6% | +40.3% | +25.9% |
| May 7, 2025 | +104.6% | -15.9% | -10.4% | -9.2% | -42.1% |
| Feb 27, 2025 | +50.0% | +3.1% | +8.7% | -12.1% | -25.0% |
| Nov 7, 2024 | +71.4% | +7.7% | +1.3% | +1.3% | +14.3% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 6, 2026 | $0.06 | $0.03 | +83.2% | $435.4M |
| May 7, 2026 | $0.04 | $0.01 | +300.0% | $403.5M |
| Feb 25, 2026 | $0.03 | -$0.00 | +3291.5% | $382.2M |
| Nov 6, 2025 | $0.00 | -$0.01 | +127.7% | $363.8M |
| Aug 7, 2025 | -$0.01 | -$0.03 | +66.7% | $345.3M |
| May 7, 2025 | $0.00 | -$0.04 | +104.6% | $333.0M |
| Feb 27, 2025 | -$0.02 | -$0.04 | +50.0% | $325.5M |
| Nov 7, 2024 | -$0.02 | -$0.07 | +71.4% | $312.7M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 91.2× | — | — | Top 27% |
| P/E (forward) | 73.7× | — | — | — |
| EV / EBITDA | 34.7× | — | — | Top 31% |
| EV / Sales | 2.88× | — | — | Top 38% |
| Free-cash-flow yield | 4.58% | — | — | Top 19% |
| Earnings yield | 1.10% | — | — | Top 27% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 227
- 50-day average slope (20 days)
- +5.4%
- 200-day average slope (20 days)
- +7.3%
- Distance from 50-day average
- -1.7%
- Distance from 200-day average
- +34.5%
- RSI (14)
- 41.3
- Relative volume
- 0.64×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 37.6%
- Volatility vs own 5-year history
- 18th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.69
- Correlation with S&P 500
- 0.23
- Current drawdown from 1-year high
- -11.6%
- Maximum drawdown, 3 years
- -56.5%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Jul 7, 2021 | Aug 1, 2025 | -86.9% | 1022 days | Not yet recovered |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $4.59B
- P/E (TTM)
- 91.2
- EPS, diluted (TTM)
- $0.13
- Revenue (TTM)
- $1.58B
- 52-week range
- $4.77 – $13.56
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $667.5M | $859.5M | $1.06B | $1.25B | $1.42B |
| Gross profit | $201.5M | $237.0M | $302.1M | $402.4M | $461.1M |
| Operating income | -$286.4M | -$210.2M | -$189.1M | -$31.6M | $24.1M |
| Net income | -$307.2M | -$215.6M | -$186.3M | -$57.4M | $9.7M |
| EPS (diluted) | -$1.05 | -$0.61 | -$0.51 | -$0.15 | $0.02 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $312.7M | $325.5M | $333.0M | $345.3M | $363.8M | $382.2M | $403.5M | $435.4M |
| Net income | -$6.0M | -$7.1M | $709,000 | -$3.8M | $1.1M | $11.7M | $14.2M | $23.6M |
| EPS (diluted) | -$0.02 | -$0.02 | $0.00 | -$0.01 | $0.00 | $0.03 | $0.04 | $0.06 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $9.4M | $52.8M | -$16.9M | $107.3M | $146.2M |
| Capital expenditure | -$94.5M | -$79.3M | -$40.5M | -$21.6M | -$36.1M |
| Free cash flow | -$85.1M | -$26.5M | -$57.4M | $85.7M | $110.0M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $549.9M | -$904,000 | $0 | $0 | $0 |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $225.9M
- Total assets
- $2.18B
- Total liabilities
- $704.3M
- Total debt
- $200.7M
- Net debt
- -$25.3M
- Shareholders’ equity
- $1.48B
As of Jun 30, 2026 (filed Aug 6, 2026).
Short interest
- Shares sold short
- 16,260,201
- Days to cover
- 3.07
- Change vs previous report
- +19.4%
FINRA short interest, settlement date Sep 15, 2026.